FDA Inspection
Dr. Bruce G. Rankin, DODr. Bruce G. Rankin, DO – FDA Inspection, Sep 22, 2023
Record Details
This FDA Inspection record concerns Dr. Bruce G. Rankin, DO, with an inspection on September 22, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · fa7388fb-83c0-415e-ac47-352c64837f6a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1218367
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.60FD-1572, protocol compliance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Dr. Bruce G. Rankin, DO
5| Date | Classification | Office | Project area |
|---|---|---|---|
| November 24, 2020 | NAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
| May 8, 2015 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| February 25, 2014 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| January 26, 2010 | NAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
| January 12, 2010 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Dr. Bruce G. Rankin, DO
- FDA Inspection 1133732 - 2020-11-24
- FDA Inspection 927571 - 2015-05-08
- FDA Inspection 867756 - 2014-02-25
- FDA Inspection 642563 - 2010-01-26
- FDA Inspection 646078 - 2010-01-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.